Trial Profile
Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Dulaglutide; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 May 2021 Status changed from recruiting to completed.
- 14 Nov 2018 New trial record